The Ambulatory Medical Assistance (AMA) programme during active-phase treatment in patients with haematological malignancies: A cost-effectiveness analysis.

Context: The need for patient navigator is growing, and there is a lack of cost evaluation, especially during survivorship.

Objective: The objective of this study is to evaluate the cost-effectiveness of an Ambulatory Medical Assistance (AMA) programme in patients with haematological malignancies (HM).

Design: A cost-effectiveness analysis of the AMA programme was performed compared to a simulated control arm.